Krempa Davidinsider trades
In SEC Form 4 filings, Krempa David is listed as Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON). In the last 90 days, Krempa David sold $1.86M of Eton Pharmaceuticals, Inc. (ETON) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ETONEton Pharmaceuticals, Inc. | Chief Business Officer | 6 | Oct 6 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ETONEton Pharmaceuticals, Inc. | Oct 6 | Oct 6 | S | 4,166 | $55.07 | Sale −$229,406 | 43,381 | No | Form 4 |
| ETONEton Pharmaceuticals, Inc. | Oct 2 | Oct 6 | M | 10,522 | not reported | not reported | 47,547 | No | Form 4 |
| ETONEton Pharmaceuticals, Inc. | Oct 2 | Oct 6 | M · derivative | 10,522 | $0.00 | $0 | 21,044 | No | Form 4 |
| ETONEton Pharmaceuticals, Inc. | Aug 24 | Aug 24 | M | 25,000 | $7.31 | $182,750 | 62,025 | No | Form 4 |
| ETONEton Pharmaceuticals, Inc. | Aug 24 | Aug 24 | S | 25,000 | $65.07 | Sale −$1,626,750 | 37,025 | No | Form 4 |
| ETONEton Pharmaceuticals, Inc. | Aug 24 | Aug 24 | M · derivative | 25,000 | $7.31 | $182,750 | 70,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.